These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 203358)
41. [Long term neuroleptic therapy using fluspirilene and penfluridol]. Haase HJ; Fischer D; Floru L; Frank T; Joseph K; Knaack M; Mohr W; Richter-Peill H; Steuer A; Wahl G; Walterbusch G; Zurborn R Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761 [No Abstract] [Full Text] [Related]
42. Experience with fluspirilene (R 6218), a long-acting neuroleptic. van Epen JH Psychiatr Neurol Neurochir; 1970; 73(4):277-84. PubMed ID: 5478771 [No Abstract] [Full Text] [Related]
43. Fluspirilene in the treatment of chronic schizophrenic outpatients. St-Laurent J; Carle R; Domingue D Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682 [No Abstract] [Full Text] [Related]
44. Clinical experience with fluspirilene in psychoses. Svestka J; Náhunek K; Hádlík J; Rodová A Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825 [No Abstract] [Full Text] [Related]
45. Epidemiology of eating disorders in Africa. van Hoeken D; Burns JK; Hoek HW Curr Opin Psychiatry; 2016 Nov; 29(6):372-7. PubMed ID: 27532943 [TBL] [Abstract][Full Text] [Related]
46. [Fluspirilene, a new long-term neuroleptic. Clinical experiences from a psychiatric hospital]. Scheibner H Fortschr Med; 1972 Apr; 90(12):482-4. PubMed ID: 4629784 [No Abstract] [Full Text] [Related]
47. Acute and subchronic effects of MJ-13859, a potential antipsychotic drug, on rat brain dopaminergic function. McMillen BA J Pharmacol Exp Ther; 1985 May; 233(2):369-75. PubMed ID: 2987476 [TBL] [Abstract][Full Text] [Related]
48. [Clinical experimentation with a long-acting neuroleptic fluspirilene (R 6218)]. Luyckx A Acta Psychiatr Belg; 1972 Nov; 72(6):748-55. PubMed ID: 4679557 [No Abstract] [Full Text] [Related]
49. Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes). Wang SJ Synapse; 2002 Apr; 44(1):36-41. PubMed ID: 11842444 [TBL] [Abstract][Full Text] [Related]
50. Clinical pharmacology of eating and not eating. Melotto S Curr Opin Pharmacol; 2014 Feb; 14():1-5. PubMed ID: 24565004 [TBL] [Abstract][Full Text] [Related]
51. Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa. Monteleone AM; Castellini G; Volpe U; Ricca V; Lelli L; Monteleone P; Maj M Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):132-142. PubMed ID: 28259721 [TBL] [Abstract][Full Text] [Related]
52. [Pathological neurological and psychiatric aspects of some deficiency manifestations with digestive and neuro-endocrine disorders. II. Studies of the changes in the central nervous system in two cases of anorexia (so-called anorexia nervosa) in young girls]. MARTIN F Helv Med Acta; 1955 Nov; 22(4-5):522-9. PubMed ID: 13285828 [No Abstract] [Full Text] [Related]
53. [Depression following use of Imap 1.5 mg]. Kiltz RR MMW Munch Med Wochenschr; 1981 Apr; 123(15):611-2. PubMed ID: 6785595 [TBL] [Abstract][Full Text] [Related]
54. Quality of life in anorexia nervosa: a review of the literature. Sy R; Ponton K; De Marco P; Pi S; Ishak WW Eat Disord; 2013; 21(3):206-22. PubMed ID: 23600552 [TBL] [Abstract][Full Text] [Related]
55. [The psychiatric comorbidity of anorexia nervosa: A comparative study in a population of French and Greek anorexic patients]. Kountza M; Garyfallos G; Ploumpidis D; Varsou E; Gkiouzepas I Encephale; 2018 Nov; 44(5):429-434. PubMed ID: 29102367 [TBL] [Abstract][Full Text] [Related]
56. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice. Faltus F Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824 [No Abstract] [Full Text] [Related]